Breakthrough microbiome therapies
Advanced Microbiome Genomics & Data Science for Therapeutic Discovery
Proprietary databases and analytics pipelines combine to create a powerful discovery engine for new microbiome products.
Healthy microorganisms can act as a barrier against dangerous pathogens. Resilient is developing a new class of therapeutics designed from the commensal microbial community.
Resilient is actively testing non-antibiotic, precision microbial therapeutics to prevent respiratory infectious diseases.
Stay informed of the latest updates and company news from the Resilient Biotics team